Effects of prolonged treatment with compound 48/80 on the gastric mucosa and mast cells in the rat
- PMID: 4032856
- DOI: 10.1254/jjp.38.195
Effects of prolonged treatment with compound 48/80 on the gastric mucosa and mast cells in the rat
Abstract
Effects of prolonged administration of compound 48/80 (48/80) on the gastric mucosa, serotonin and histamine levels in serum, and mast cells of rats were studied. Daily administration of 48/80 (0.75 mg/kg, i.p.) for 2 or 4 days produced widespread gastric lesions. Further administration of the agent for up to 12 days did not aggravate the lesions which had developed in the early period of administration of the drug. There were only a few visible lesions and numerous healed ones. Almost the same phenomenon was observed with the daily administration of serotonin plus histamine (10 mg/kg each, i.p.) for 2 to 12 days. While 48/80 given for 2 or 4 days increased serotonin and histamine levels in serum, it induced no appreciable increase of these amines after 8 or 12 days of treatment. Serotonin and histamine levels in peritoneal mast cells significantly decreased after the treatment with 48/80 over a 4 day period. The decrease in gastric lesions after prolonged treatment with 48/80 is due to both the depletion of serotonin and histamine from mast cells and an increased resistance of the gastric mucosa with healed lesions.
Similar articles
-
Pathogenesis of compound 48/80-induced gastric lesions in rats.Dig Dis Sci. 1986 Apr;31(4):392-400. doi: 10.1007/BF01311675. Dig Dis Sci. 1986. PMID: 3956335
-
Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator.Pharmacol Res. 1999 Apr;39(4):261-7. doi: 10.1006/phrs.1998.0403. Pharmacol Res. 1999. PMID: 10208755
-
Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.Biol Pharm Bull. 2005 Aug;28(8):1424-30. doi: 10.1248/bpb.28.1424. Biol Pharm Bull. 2005. PMID: 16079487
-
Repeated recurrence of gastric mucosal lesions in rats after a single treatment with compound 48/80, a mast cell degranulator.J Physiol Pharmacol. 2009 Dec;60 Suppl 7:139-48. J Physiol Pharmacol. 2009. PMID: 20388957
-
Histological evaluation of mast cells in rat gastric mucosal lesions induced by compound 48/80.Digestion. 1989;43(1-2):87-97. doi: 10.1159/000199866. Digestion. 1989. PMID: 2806759
Cited by
-
Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system.Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):547-57. doi: 10.1007/BF00260610. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2482449
-
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.Psychopharmacology (Berl). 2011 Aug;216(3):323-31. doi: 10.1007/s00213-011-2224-5. Epub 2011 Feb 22. Psychopharmacology (Berl). 2011. PMID: 21340468 Free PMC article.
-
Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action.Naunyn Schmiedebergs Arch Pharmacol. 1989 Aug;340(2):170-9. doi: 10.1007/BF00168965. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2478892
-
Roles of in vitro- and in vivo-administered histamine and serotonin in compound 48/80-induced gastric acid secretion in isolated, perfused rat stomach.Dig Dis Sci. 1991 Dec;36(12):1708-14. doi: 10.1007/BF01296614. Dig Dis Sci. 1991. PMID: 1748039
-
Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats.Agents Actions. 1994 Mar;41(1-2):21-4. doi: 10.1007/BF01986388. Agents Actions. 1994. PMID: 7521568
MeSH terms
Substances
LinkOut - more resources
Full Text Sources